» Articles » PMID: 23384748

Oral Contraceptives in Adolescent Women

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2013 Feb 7
PMID 23384748
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Taking into account the biological and psychosocial changes during the transition from childhood to adulthood adolescents would need a contraceptive method which ideally would be very effective, independent of compliance, without major health risks during use and no negative impact on the future health of the adolescent, protective against STI, favorable for bone development, with no or only few side effects and having some preventive and therapeutic potential with respect to frequent health problems of adolescent girls. Combined oral contraceptives (COC) used regularly and consistently have a more than 99% efficacy to prevent a pregnancy. COCs have a very low health risk (almost exclusively thromboembolic disease) which seems to differ marginally with respect to dosage and type of the components. Progestogen only oral contraceptives do not have any major negative health impact. The leading side effect is irregular bleeding which in COC users is mainly during the first 3 months and in progestogen only users during the period of use. Other side effects are reported but their frequency is similar to placebo. COC protect against endometrial and ovarian cancer and they may have beneficial effects on a variety of menstrual complaints and acne, which are frequent problems during adolescence. To be effective COCs have to be taken regularly which is frequently not the case. This diminishes considerably their effectiveness depending on the individual compliance. They do not protect against STI and may even have an inhibitory effect on the use of condoms. For most adolescents the risk benefit profile of oral contraceptives is favorable and makes this method valuable. At the same time the prescription of oral contraceptives for adolescents need to be individualized by taking into account the individual risk/benefit profile. Specialized counseling with a high degree of confidentiality adapted to the knowledge and needs of the individual adolescent is desirable.

Citing Articles

Effects of management of heavy menstrual bleeding of patients undergoing haploidentical hematopoietic stem cell transplantation.

Han R, Zhang F, Jiang X, Wang C, Yang X Int J Gynaecol Obstet. 2024; 168(2):580-590.

PMID: 39264070 PMC: 11726145. DOI: 10.1002/ijgo.15905.


Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4).

Creinin M, Cagnacci A, Spaczynski R, Stute P, Chabbert-Buffet N, Korver T Front Glob Womens Health. 2024; 5:1395863.

PMID: 38655395 PMC: 11035732. DOI: 10.3389/fgwh.2024.1395863.


Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.

Hedayati M, Rajabi S, Nikzamir A Galen Med J. 2021; 9:e1648.

PMID: 34466561 PMC: 8343887. DOI: 10.31661/gmj.v9i0.1648.


Oral contraceptive use is not related to gender self-concept.

Nielson M, Beltz A Psychoneuroendocrinology. 2021; 129:105271.

PMID: 34030085 PMC: 8265989. DOI: 10.1016/j.psyneuen.2021.105271.


Trends in the use of oral contraceptives among adolescents and young women in Spain.

Carrasco-Garrido P, Lopez de Andres A, Hernandez-Barrera V, Jimenez-Trujillo I, Esteban-Pena M, Perez-Farinos N Reprod Health. 2016; 13(1):122.

PMID: 27664123 PMC: 5035482. DOI: 10.1186/s12978-016-0239-4.